PFIZER INC. DL-,05 | 30.5150 / +0.94% |
News
- France to lengthen wait between vaccine doses - Veran
04/11/2021 / 01:49 - TeleTrader - S. African strain better at bypassing Pfizer jab - Israeli scientists
04/10/2021 / 23:10 - TeleTrader - Pfizer asks FDA to widen jab EUA to those aged 12-15
04/09/2021 / 19:34 - TeleTrader - EU to order 1.8B vaccine doses for 2022,2023 - report
04/09/2021 / 16:33 - TeleTrader - Australia secures another 20M Pfizer vaccine doses - PM
04/09/2021 / 06:01 - TeleTrader - NIH to study allergic reactions to COVID-19 vaccines
04/07/2021 / 16:07 - TeleTrader - France to receive 12M vaccine doses in April - Veran
04/06/2021 / 16:26 - TeleTrader - Pfizer-BioNTech vaccine 'highly effective' for 6 months
04/01/2021 / 13:03 - TeleTrader - Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study
04/01/2021 / 12:45 - GlobeNewswire - Pfizer: COVID vaccine 100% effective in children aged 12-15
03/31/2021 / 12:49 - TeleTrader - Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents
03/31/2021 / 12:45 - GlobeNewswire - Pfizer, BioNTech to up vaccine production to 2.5B doses in 2021
03/30/2021 / 12:50 - TeleTrader - Single dose of Pfizer, Moderna shots 80% effective - study
03/29/2021 / 17:13 - TeleTrader - WH weighs allowing countries to replicate COVID vaccines
03/26/2021 / 22:19 - TeleTrader - EMA Approves New Storage Option for Pfizer-BioNTech Vaccine, Easing Distribution and Storage of Doses Across European Union
03/26/2021 / 14:20 - GlobeNewswire